Cost

24 drugs in development·15 companies·1 clinical trial

Drug Pipeline by Phase

Approved(21)

Drug	Company
asmanex hfa	Organon & Co. (OGN)
breyna	Mylan II B.V. (MYL)
byqlovi	HARROW, INC. (IMMY)
clobetasol	Amneal Pharmaceuticals, Inc. (AMRX)
deflazacort	Amneal Pharmaceuticals, Inc. (AMRX)
dulera	Organon & Co. (OGN)
fluocinonide	Amneal Pharmaceuticals, Inc. (AMRX)
fluorometholone	Amneal Pharmaceuticals, Inc. (AMRX)
halcinonide	Mylan II B.V. (MYL)
lidocaine	MANNKIND CORP (MNKD)
ozurdex	AbbVie Inc. (ABBV)
prednisone	DR REDDYS LABORATORIES LTD (RDY)
promacta	Novartis AG (NVS)
promacta kit	Novartis AG (NVS)
sirolimus	Amneal Pharmaceuticals, Inc. (AMRX)
tobradex st	HARROW, INC. (IMMY)
tofidence	BIOGEN INC. (BIIB)
triamcinolone acetonide	Miromatrix Medical Inc. (MIRO)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
wixela inhub	Mylan II B.V. (MYL)
xhance	Paratek Pharmaceuticals, Inc. (PRTK)

Phase 3(1)

Drug	Company
semdexa	Sorrento Therapeutics, Inc. (SRNE)

Unknown(2)

Drug	Company
EPICORD Expandable	MiMedx Group Inc (MDXG)
FitYourOutfit® (FYO) Body Composition System	BIOADAPTIVES, INC. (BDPT)

BioSniper tracks 24 drugs in development for Cost across 15 companies.

There are 1 clinical trial targeting Cost tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.